Associated Papers
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
Linder A et al.
Human Reproduction (oxford, England), 2024
Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine.
De Pieri M et al.
Frontiers in Pharmacology, 2023
Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa.
Boukhalfa W et al.
Frontiers in Aging Neuroscience, 2023
New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3, CSMD1 and NRG1 genes.
Mestiri S et al.
Molecular Genetics & Genomic Medicine, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.
Bateman NW et al.
Iscience, 2022
Genomic Markers for Essential Tremor.
Jiménez-Jiménez FJ et al.
Pharmaceuticals (basel, Switzerland), 2021
Introducing the first whole genomes of nationals from the United Arab Emirates.
AlSafar HS et al.
Scientific Reports, 2019
Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease.
Redenšek S et al.
Frontiers in Pharmacology, 2019
Non-invasive genotyping with a massively parallel sequencing panel for the detection of SNPs in HPA-axis genes.
Gutleb DR et al.
Scientific Reports, 2018
Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.
Comi C et al.
International Journal of Molecular Sciences, 2017
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.
Ferrari M et al.
European Journal of Clinical Pharmacology, 2016
Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.
Cosentino M et al.
Human Immunology, 2015
Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor.
Mao X et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 2013
Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia.
Proitsi P et al.
Neurobiology of Aging, 2012
Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts.
Muglia P et al.
Molecular Psychiatry, 2010
Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients.
Lorenz D et al.
European Journal of Human Genetics : Ejhg, 2009
Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T et al.
Pharmacogenetics and Genomics, 2008
Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.
Werge T et al.
The Pharmacogenomics Journal, 2003
Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases.
Rietschel M et al.
Schizophrenia Research, 1996